<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on September 20, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/ct2/show/NCT02970370</url>
  </required_header>
  <id_info>
    <org_study_id>Cairo-5-UMP</org_study_id>
    <nct_id>NCT02970370</nct_id>
  </id_info>
  <brief_title>Demographics, Clinical and Paraclinical Characteristics of Multiple Sclerosis in Egypt</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <brief_summary>
    <textblock>
      The primary study aim is to depict the demographics, clinical and para clinical features of&#xD;
      patients attending five tertiary referral multiple sclerosis (MS) centers in Egypt.&#xD;
&#xD;
      This requires effective and unified pooled registries to extract data from with a&#xD;
      standardized, sufficient and high quality clinical, magnetic resonance imaging (MRI) data,&#xD;
      neurophysiological data and body fluids.&#xD;
&#xD;
      Investigators want to shed light on the challenges that face both physicians and patients in&#xD;
      the area of &quot;diagnosis and treatment&quot;&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2015</start_date>
  <primary_completion_date type="Actual">July 2016</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
  </study_design_info>
  <target_duration>15 Years</target_duration>
  <primary_outcome>
    <measure>portrayed phenotypes and para-clinical data of Egyptian Multiple Sclerosis Patients</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <enrollment type="Actual">2752</enrollment>
  <condition>Multiple Sclerosis</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>no intervention</intervention_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Radiologically isolated syndrome, Clinically isolated Syndrome , Multiple Sclerosis,&#xD;
        Neuromyelitis optica spectrum disorders (NMOSD), MS mimics&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with MS/NMOSD or their mimics who sought advice in one of our centers even&#xD;
             once&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with missing data in their records that couldn't be completed&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>November 2016</verification_date>
  <study_first_submitted>November 18, 2016</study_first_submitted>
  <study_first_submitted_qc>November 21, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 22, 2016</study_first_posted>
  <last_update_submitted>November 21, 2016</last_update_submitted>
  <last_update_submitted_qc>November 21, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 22, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Hatem Samir Shehata</investigator_full_name>
    <investigator_title>Professor of Neurology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Multiple Sclerosis</mesh_term>
    <mesh_term>Sclerosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>


download date: ClinicalTrials.gov processed this data on September 20, 2023
link text: Link to the current ClinicalTrials.gov record.
url: https://clinicaltrials.gov/ct2/show/NCT02970370
org study id: Cairo-5-UMP
nct id: NCT02970370
lead sponsor: 
The primary study aim is to depict the demographics, clinical and para clinical features of
      patients attending five tertiary referral multiple sclerosis (MS) centers in Egypt.

      This requires effective and unified pooled registries to extract data from with a
      standardized, sufficient and high quality clinical, magnetic resonance imaging (MRI) data,
      neurophysiological data and body fluids.

      Investigators want to shed light on the challenges that face both physicians and patients in
      the area of "diagnosis and treatment"
observational model: Cohort
measure: portrayed phenotypes and para-clinical data of Egyptian Multiple Sclerosis Patients
time frame: 6 months
intervention type: Other
intervention name: no intervention
study pop: 
sampling method: Non-Probability Sample
criteria: 
gender: All
minimum age: N/A
maximum age: N/A
healthy volunteers: No
responsible party type: Principal Investigator
investigator affiliation: Cairo University
investigator full name: Hatem Samir Shehata
investigator title: Professor of Neurology
mesh term: Multiple Sclerosis
mesh term: Sclerosis